PCRB vs SPY

PCRB vs SPY

Which is better, PCRB or SPY?

Investment Grade Bond against Large Cap Blend.

SPY has a lower expense ratio. SPY led over 1Y and the full window.

Lower Fees: SPYHigher Returns: SPY

MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.

Side-by-Side Comparison

MetricPCRBSPY
Expense Ratio0.36%0.09%Best
AUM$7M$804.7B
Dividend Yield9.74%0.98%
Holdings568505
Volatility (annualized)5.6%Best12.9%
Max Drawdown-7.2%Best-18.8%
$10,000 over 3.4 years$11,141$19,482Best
Fund FamilyFranklin Templeton Investments (US)State Street Investment Management
CategoryFixed IncomeEquity
StyleInvestment Grade BondLarge Cap Blend
InceptionJan 19, 2023Jan 22, 1993

Not shown on this pair: YTD Return, 1Y Return, 3Y Return (annualized), 5Y Return (annualized), Top 10 Weight.

The two price series end 94 days apart, so a return over any period would be measuring two different stretches of market. Those rows are withheld. PCRB has data through Jun 9, 2026 and SPY through Sep 11, 2026.

Volatility and max drawdown, and the $10,000 over 3.4 years row, are measured over the window both funds cover: Jan 20, 2023 to Jun 9, 2026 (3.4 years).

Risk: Volatility and Drawdowns

SPY has been the more volatile fund, with annualized monthly volatility of 12.9% compared with 5.6% for PCRB. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.

The deepest peak-to-trough decline in our data was -7.2% for PCRB and -18.8% for SPY. Drawdown depth is what each fund did in the worst stretch of the window measured above.

The two funds' monthly returns correlate at 0.51. They move together some of the time, and apart the rest.

Fees and Cost Over Time

PCRB charges 0.36% per year while SPY charges 0.09%. On a $10,000 position that is $36 vs $9 annually, a gap of $27 per year that compounds over a long holding period. On income, PCRB currently yields 9.74% against 0.98% for SPY.

Holdings Overlap

SPY already in PCRB0.5%

At least 0.5% of SPY's money is in holdings PCRB also owns.

Stated as a floor: for PCRB, our book for it covers 82.5% of that fund, so a holding it does not list is one we cannot count as shared. The real figure is this or higher.

We cannot see either book well enough to say how much of this pair is duplicated.

The two holdings books were reported 186 days apart, PCRB as of Jan 30, 2026 and SPY as of Aug 4, 2026, so some of the difference between them is the time between the two reports rather than the funds.

2 positions in common, counted across the 381 positions we hold weights for in PCRB and 504 in SPY, against full books of 568 and 505.

Top Shared Holdings

StockWeight in PCRBWeight in SPYDifference
CCitigroup Inc 6.875 11/73 6.88 2173-11-150.17%0.35%0.18%
TMUST-Mobile Usa, Inc. 3.875% 15-Apr-20300.34%0.12%0.22%

You are not choosing between two funds in isolation.

Whichever of PCRB and SPY you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.

PCRBSPY

Free for up to 10 holdings. No account needed.

Frequently Asked Questions

Which is cheaper, PCRB or SPY?

PCRB has an expense ratio of 0.36% while SPY charges 0.09%. SPY is the cheaper option, by $27 a year on a $10,000 investment.

Which is riskier, PCRB or SPY?

SPY has been the more volatile fund at 12.9% annualized versus 5.6% for PCRB. Worst drawdown: PCRB -7.2% vs SPY -18.8%.

Should I hold both PCRB and SPY?

PCRB and SPY have a monthly-return correlation of 0.51, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.

Which pays a higher dividend, PCRB or SPY?

PCRB yields 9.74% while SPY yields 0.98%, so PCRB currently pays the higher dividend yield.

Is SPY better than PCRB?

SPY has a lower expense ratio. SPY led over 1Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.